Literature DB >> 19902462

Enhancing clinical trial design of interventions for posttraumatic stress disorder.

Andrew C Leon1, Lori L Davis.   

Abstract

The 2008 Institute of Medicine review of interventions research for posttraumatic stress disorder (PTSD) concluded that new, well-designed studies are needed to evaluate the efficacy of treatments for PTSD. The Department of Veterans Affairs (VA), the Department of Defense, and the National Institute of Mental Health convened a meeting on research methodology and the VA issued recommendations for design and analysis of randomized controlled clinical trials (RCTs) for PTSD. The rationale that formed the basis for several of the components of the recommendations is discussed here. Fundamental goals of RCT design are described. Strategies in design and analysis that contribute to the goals of an RCT and thereby enhance the likelihood of signal detection are considered.

Entities:  

Mesh:

Year:  2009        PMID: 19902462      PMCID: PMC2798901          DOI: 10.1002/jts.20466

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  47 in total

1.  Sixteen S-squared over D-squared: a relation for crude sample size estimates.

Authors:  R Lehr
Journal:  Stat Med       Date:  1992-06-15       Impact factor: 2.373

2.  Approximate multinormal probabilities applied to correlated multiple endpoints in clinical trials.

Authors:  S James
Journal:  Stat Med       Date:  1991-07       Impact factor: 2.373

Review 3.  Clinical trials in psychiatry: should protocol deviation censor patient data?

Authors:  P W Lavori
Journal:  Neuropsychopharmacology       Date:  1992-01       Impact factor: 7.853

4.  Missing data in longitudinal studies.

Authors:  N M Laird
Journal:  Stat Med       Date:  1988 Jan-Feb       Impact factor: 2.373

5.  The analysis of multiple endpoints in clinical trials.

Authors:  S J Pocock; N L Geller; A A Tsiatis
Journal:  Biometrics       Date:  1987-09       Impact factor: 2.571

6.  More reliable outcome measures can reduce sample size requirements.

Authors:  A C Leon; P M Marzuk; L Portera
Journal:  Arch Gen Psychiatry       Date:  1995-10

Review 7.  Between-group therapy outcome research: design and methodology.

Authors:  T D Borkovec
Journal:  NIDA Res Monogr       Date:  1993

8.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

9.  A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study.

Authors:  Lori L Davis; Michele E Jewell; Sandra Ambrose; Jason Farley; Brett English; Al Bartolucci; Frederick Petty
Journal:  J Clin Psychopharmacol       Date:  2004-06       Impact factor: 3.153

10.  A controlled trial of desipramine in 18 men with posttraumatic stress disorder.

Authors:  C Reist; C D Kauffmann; R J Haier; C Sangdahl; E M DeMet; A Chicz-DeMet; J N Nelson
Journal:  Am J Psychiatry       Date:  1989-04       Impact factor: 18.112

View more
  14 in total

1.  Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder.

Authors:  Louisa G Sylvia; Noreen A Reilly-Harrington; Andrew C Leon; Christine I Kansky; Terence A Ketter; Joseph R Calabrese; Michael E Thase; Charles L Bowden; Edward S Friedman; Michael J Ostacher; Dan V Iosifescu; Joanne Severe; Michelle Keyes; Andrew A Nierenberg
Journal:  Clin Trials       Date:  2011-11-10       Impact factor: 2.486

2.  The role and interpretation of pilot studies in clinical research.

Authors:  Andrew C Leon; Lori L Davis; Helena C Kraemer
Journal:  J Psychiatr Res       Date:  2010-10-28       Impact factor: 4.791

3.  To attend, or not to attend: Examining caregiver intentions and study compliance in a pediatric, randomized controlled trial.

Authors:  Jacqueline A Sullivan; Anna M Wiese; Kelly M Boone; Joseph Rausch; Sarah A Keim
Journal:  Clin Trials       Date:  2020-01-27       Impact factor: 2.486

4.  Posttraumatic stress disorder symptoms among family decision makers and the potential relevance of study attrition.

Authors:  Ann M Parker; O Joseph Bienvenu
Journal:  Crit Care Med       Date:  2015-06       Impact factor: 7.598

Review 5.  Pharmacological treatment of PTSD - established and new approaches.

Authors:  Thomas Steckler; Victoria Risbrough
Journal:  Neuropharmacology       Date:  2011-06-29       Impact factor: 5.250

Review 6.  Aligning use of intensive care with patient values in the USA: past, present, and future.

Authors:  Alison E Turnbull; Gabriel T Bosslet; Erin K Kross
Journal:  Lancet Respir Med       Date:  2019-05-20       Impact factor: 30.700

7.  Evolution of psychopharmacology trial design and analysis: six decades in the making.

Authors:  Andrew C Leon
Journal:  J Clin Psychiatry       Date:  2011-03       Impact factor: 4.384

Review 8.  Psychosocial interventions for late-life major depression: evidence-based treatments, predictors of treatment outcomes, and moderators of treatment effects.

Authors:  Dimitris N Kiosses; Andrew C Leon; Patricia A Areán
Journal:  Psychiatr Clin North Am       Date:  2011-06

9.  Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.

Authors:  David E Kemp; Keming Gao; Elizabeth B Fein; Philip K Chan; Carla Conroy; Sarah Obral; Stephen J Ganocy; Joseph R Calabrese
Journal:  Bipolar Disord       Date:  2012-11       Impact factor: 6.744

Review 10.  Evaluation of psychiatric interventions in an observational study: issues in design and analysis.

Authors:  Andrew C Leon
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.